Menu

US Research Integrity Head Temporarily Leaves Post

Kathy Partin, whose staff had expressed concerns about changes she instituted, was reportedly asked to leave.

Nov 21, 2017
Kerry Grens

Kathy Partin, ORIUS HEALTH AND HUMAN SERVICESFor two tumultuous years, Kathy Partin has led the US Office of Research Integrity (ORI), the government organization tasked with investigating claims of scientific misconduct among federal grant recipients. Retraction Watch reports that as of December 4, Partin will be on leave for three months, having been assigned a temporary position at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. The move marks what could be the end of Partin’s tenure as ORI director.

“They’ve basically told her she’s not going back,” Linda Schutjer, Partin’s former colleague at Colorado State University, tells Retraction Watch. “They’ve told her to take all her stuff out of her office, all of her personal things.” Retraction Watch was unable to confirm Schutjer’s claim with Partin, who declined to comment.

Partin’s leadership of the ORI has been controversial. As Science reported last year, Partin came in seeking to shake up the agency—conducting an office-wide review and bringing in a deputy from the National Science Foundation, whose integrity enforcement is more expansive.

ORI’s investigative staff responded at the time with complaints to supervisors at Health and Human Services (HHS), the department that oversees the ORI. In a letter to HHS, six staff members described “tensions and conflict [that are] tearing this office apart,” according to Science.

While Partin is away, Wanda Jones, the former principal deputy assistant secretary at HHS, will serve as interim director. 

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!